Thomas D. Carey
CIK 1574633 · last filed 2026-06-23
Thomas D. Carey is a corporate insider who has filed 25 SEC Form 4 insider transactions across 3 companies since 2013. The most recent filing, for LAB, was dated Jun 23, 2026. Across all open-market trades the lifetime net is −$7.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $221.6K across reported positions. 18 SEC filings were submitted jointly with EXACT SCIENCES CORP.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
EXAS price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
HINGHAM, MA 02043
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LAB | Director | 344,456 | $0.64 | $221.6K | $0 | 6 | 2026-06-23 |
| SomaLogic, Inc. (SLGCW) Delisted | Director | — | $0.09 | — | $0 | 1 | 2023-06-12 |
| EXACT SCIENCES CORP (EXAS) Delisted | Director | 5,292 | $104.91 | $555.2K | -$7.06M | 17 | 2021-06-03 |
Recent Filings
25 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-23 | LAB | Grant (A) | +99,116 | $0 | EDGAR |
| 2026-03-02 | LAB | Grant (A) | +51,282 | $60.0K | EDGAR |
| 2025-06-24 | LAB | Grant (A) | +94,592 | $0 | EDGAR |
| 2025-03-04 | LAB | Grant (A) | +56,338 | $60.0K | EDGAR |
| 2024-07-02 | LAB | Grant (A) | +43,128 | $0 | EDGAR |
| 2024-01-09 | LAB | Grant (A) | +79,412 | $0 | EDGAR |
| 2024-01-09 | — | Disp (D) | — | $0 | |
| 2023-06-12 | SomaLogic, Inc. (SLGCW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-03 | EXACT SCIENCES CORP (EXAS) Delisted | Sell (S) | −17,000 | -$1.84M | EDGAR |
| 2020-10-23 | EXACT SCIENCES CORP (EXAS) Delisted | Grant (A) | +420 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.